ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $3.34M invested in Entero Therapeutics in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$421K
2
+$167K

Top Sellers

1
-$1.28M
2
-$178K
3
-$154K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$92K
5
BlackRock
BlackRock
New York
-$75K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$842K
2
$667K
3
$650K
4
$524K
5
$182K
6
$159K
7
$89K
8
$73K
9
$45K
10
$34K
11
$28K
12
$15K
13
$12K
14
$12K
15
$2K
16
$2K
17
–
18
–
19
–